tbuckley/cabot-search huggingface dataset:
You Too Can Have a Baby (A Plan for Parenthood)
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Intellectual Status of Children with Sickle Cell Anemia
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Iron in Enriched Wheat Bread
Authors: Margaret Ann Krikker
Journal: JAMA (1972)

<h3>To the Editor.—</h3> The EDITORIAL "Iron 'Undercontamination'?" by Dr. C. E. Butterworth, Jr. (220:581, 1972) has been widely quoted in the lay press as supporting the proposal to fortify flour and its related products with unnatural levels of iron. Since a<i>JAMA</i>EDITORIAL is generally construed by the membership of the American Medical Association and by the public as representing an official position of the AMA, clarification of Dr. Butterworth's EDITORIAL is in order. The proposed superfortification proposal is highly controversial. The House of Delegates of the AMA took cognizance of this controversy by adopting a resolution on June 24, 1971, requesting the Food and Drug Administration to hold public hearings on the safety of that proposal. It is surprising that the EDITORIAL concerning this subject should have made no mention of that resolution. It is equally surprising that a review article of the fortification conflict by the Council on
Safety and efficacy of single-agent rovalpituzumab tesirine (SC16LD6.5), a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC) in recurrent or refractory small cell lung cancer (SCLC).
Authors: Charles M. Rudin, Maria Catherine Pietanza, Todd Michael Bauer, David R. Spigel, Neal Ready, Daniel Morgensztern, Bonnie S. Glisson, Lauren Averett Byers, Melissa Lynne Johnson, Howard A. Burris, Francisco Robert, Donald K Strickland, Hany Zayed, Ramaswamy Govindan, Scott Dylla, Stanford L. Peng
Journal: Journal of Clinical Oncology (2016)

LBA8505 The full, final text of this abstract will be available at abstracts.asco.org at 7:30 AM (EDT) on Sunday, June 5, 2016, and in the Annual Meeting Proceedings online supplement to the June 20, 2016, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.
Data Errors in Table
Authors: Michael Camilleri
Journal: JAMA (2021)

randomly assigned to groups that received 4 or 10 sessions of CBT or education over 10 weeks.This study 4 showed that baseline levels of anxiety and anxiety sensitivity (fear of arousal symptoms) were associated with improved gastrointestinal symptoms following CBT compared with IBS education.Moreover, a recent study, 5 based on latent class analysis of 1375 adults in the community self-identifying as having IBS, demonstrated that 53% had a high psychological burden with diverse gastrointestinal symptom profiles.This finding supports the notion that patients with psychological comorbidity can be identified and treated with psychotherapy, rather than using the resource for all patients with IBS.It is also worth noting that there was higher IBS severity (based on the Irritable Bowel Syndrome Symptom Severity Scale [IBS-SSS]) in those with high psychological burden. 5 The numbers needed to treat between pharmacological and behavioral therapies cited by Taft and colleagues are not strictly comparable, given the absence of a true sham control group with behavioral therapies.In addition, although the Clinical Global Impressions-Improvement Scale for IBS symptoms with behavioral therapy was superior to education alone during 1 year of follow-up in the IBSOS study, 4 it is noteworthy that there were no significant differences throughout the 12 months in the severity of IBS based on the IBS-SSS. 6
Aerospace Medicine, St. Paul
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
High-Frequency Electric Currents in Medicine and Dentistry.
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Aspergillus spinal epidural abscess
Authors: B. F. Byrd
Journal: JAMA (1982)

A spinal epidural abscess developed in a renal transplant recipient; results of a serum radioimmunoassay for<i>Aspergillus</i>antigen were positive. Laminectomy disclosed an abscess of the L4-5 interspace and L-5 vertebral body that contained hyphal forms and from which<i>Aspergillus</i>species was cultured. Serum<i>Aspergillus</i>antigen radioimmunoassay may be a valuable, specific early diagnostic test when systemic aspergillosis is a consideration in an immunosuppressed host. (<i>JAMA</i>1982;248:3138-3139)
Devolution poses challenges for tackling health inequalities
Journal: BMJ (1999)

Haemophilus influenzae type b vaccine is not linked to diabetes Environmental risk factors for type 1 diabetes remain unknown.It has been speculated that some vaccines might trigger it, although data are lacking.On p 1169 Karvonen et al describe their findings from a nationwide randomised study on the association between Haemophilus influenzae type b vaccination and type 1 diabetes in Finland, which has the highest incidence of type 1 diabetes.The risk of type 1 diabetes during the first 10 years of life was similar in children vaccinated with H influenzae type b at 3 months and those immunised at 24 months only.Moreover, the incidence of the disease in the immunised children was no different from that in those children born during the two years before the start of the vaccination programme.It is unlikely that H influenzae vaccination causes type 1 diabetes in children.
Monarticular Trauma and Rheumatoid Arthritis
Journal: Annals of the Rheumatic Diseases (1952)

the administration of cortisone resulted in any benefit whatever.As to the authors' claim that it enabled pregnancy to be carried on for some weeks longer than would otherwise have been possible, the question arises whether this continuation was not sometimes, at least, at the expense of the well-being and even safety of the patient, and only to enable the cortisone trial to be extended.An example of this is in a case where there was retinal haemorrhage on admission, yet cortisone was continued for 8 days-that is, until the patient went into labour by spontaneous rupture of the membranes.She died I week later.]
FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Authors: Salah-Eddin Al-Batran, Martin H. Schuler, Zanete Zvirbule, Georgiy Manikhas, Florian Lordick, Andriy Rusyn, Yuriy Vynnyk, Ihor Vynnychenko, Natalia Fadeeva, Marina Nechaeva, Assen Dudov, Evgeny Gotovkin, Alexander Pecheniy, Igor Bazin, Igor Bondarenko, Bohuslav Melichar, Christian Mueller, Christoph Huber, Oezlem Tureci, Ugur Sahin
Journal: Journal of Clinical Oncology (2016)

LBA4001 The full, final text of this abstract will be available at abstracts.asco.org at 7:30 AM (EDT) on Sunday, June 5, 2016, and in the Annual Meeting Proceedings online supplement to the June 20, 2016, issue of the Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Monday edition of ASCO Daily News.
<i>Erratum:</i> Vol. 68, No. 12
Journal: MMWR Morbidity and Mortality Weekly Report (2019)

a percentage was misreported in multiple places.On page 277, the sixth sentence of the first paragraph should have read "Among patients with ARI who were tested, EV-D68 was detected in two patients (0.08%) in 2017 and 358 (13.9%) in 2018."On page 278, in the second section of the summary box, the first sentence should have read "Based on active, prospective surveillance of ARI through the New Vaccine Surveillance Network, EV-D68 was detected in two (0.08%) patients in 2017 and 358 (13.9%) in 2018."On page 280, the first sentence of the last paragraph should have read "Through recently established active, prospective, ARI surveillance in NVSN, EV-D68 was detected in 0.08% of patients tested in 2017 and 13.9% in 2018."
In the Year 1800.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Cross-Sectional Analysis of the Relationship Between Hormone Replacement Therapy and Coronary Artery Calcification
Authors: Amy M. Gallagher, Enrique F. Schisterman, Noel Bairey Merz, Howard C. Lewin, Sean W. Hayes, John D. Friedman, Romalisa S. Miranda, Arlene Ledesma, Daniel S. Berman
Journal: Circulation (2001)

P24 Background: There is evidence that estrogen affects the vascular wall, independent of modifications to plasma lipoproteins, by accelerating reendothelialization of damaged blood vessels and by inhibiting smooth muscle cell proliferation. Therefore, we intended to investigate the relationship between hormone replacement therapy (HRT) use and prevalence of coronary calcium (CC) in postmenopausal women. Methods: Cardiac electron beam computed tomography (EBCT) was performed on 793 postmenopausal women participating in the Cedars-Sinai Cardiovascular Observational Study. At the time of their EBCT, 509 women were receiving HRT and 284 were not receiving HRT. The total coronary calcium score was determined using the Agatston method. A self-report of HRT use was assessed in all participants, as well as measurements of other known cardiovascular risk factors. Results: Independent sample t-tests identified the means of the following variables as significantly different between the two groups of women: age, LDL, HDL, and BMI. Self reports of hypertension, smoking, exercise and diet were similar between the two groups. Analysis of variance, controlling for confounders, showed a significant difference (p&lt;.001) between the marginal means (MM) of the two HRT groups for total coronary calcium score, total number of calcified lesions, and total volume of calcium. The MM total CC score was 96.40 (±256.39) for HRT users and 150.97 (±362.54) for non-users. The MM number of lesions for users was 2.16 (±3.37) and 3.36 (±4.75) for non-users. The MM volume of calcium for users was 0.078 (±0.20) and 0.122 (±0.29) for non-users. Conclusions: Total coronary calcium score, total lesions, and total volume were found to be significantly lower in postmenopausal women receiving HRT than for those not receiving HRT. These findings support the hypothesis that hormone replacement therapy is associated with a lower prevalence of coronary calcium in postmenopausal women, which may be due to the independent effects of estrogen on coronary vessel walls.
Does lapatinib increase pulmonary toxicity when concurrently used with radiation therapy? An experimental study with Wistar albino rats.
Authors: O. Elicin, N. S. Bese, O. Yetmen, E. Guzel, M. Eser, C. Karaca, I. Coban, O. Suzer
Journal: Journal of Clinical Oncology (2011)

e11136 Background: Lapatinib (L) is an receptor tyrosine kinase inhibitor which has shown activity in the treatment of metastatic breast cancer. Adjuvant usage of L is being investigated in phase III trials. There is no data regarding toxicity of RT and L combination which may be a problem when L is used in adjuvant setting. Lung is the most radiosensitive organ to observe late effects of RT. We evaluated if concurrent L administration has any impact for the development of radiation induced pulmonary fibrosis in rats (RIPF). Methods: 40 female Wistar albino rats (WAR) were divided into 4 groups (G). G1 (control) did not receive any treatment. G2 received RT to whole thoracic region, G3 L without RT and G4 L with RT. A total dose of 30 Gy in 10 fractions was given to lungs with an anterior field at 2 cm depth. L equivalent to 1500 mg/day, 60 kg adult dose, were calculated according to the mean weight of rats, orally administrated with a feeding tube twice daily including the week-ends until WAR were sacrificed. WAR were anesthetized and sacrificed 16 weeks after RT which was shown to be a sufficient period for the development of RIPF in rats. Paraffin sections (5 µm thick) of lungs were stained with hematoxylin-eosin and Masson’s trichrome. A comparative analysis was performed among 4 groups by scoring the pulmonary injury between 0 and 3 according to the infiltration of inflammatory cells into the alveolar spaces, alveolar wall thickening and architectural deformation across the entire lung section. Normality distribution were tested, then one-way ANOVA followed by post hoc Holm-Sidak testing were used. Results: In G2 inflammatory cell infiltration, fibrosis with damage to lung and formation of small fibrous masses were observed. Alveolar septa were significantly thicker than G1 (p<0.05), which revealed normal pulmoner structure. G3 showed minimal alveolar septal thickening and infiltration of inflammatory cells into the alveolar spaces which was not significantly different than G1. Histopathological findings in G4 were similar to those in G2 and statistically different when compared with the G1 and G3 (p<0.05). Conclusions: Study shows that addition of L to RT does not increase RIPF in rats.
HAZARDS OF MULTIVITAMIN THERAPY IN UNDIAGNOSED PERNICIOUS ANEMIA
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
DOMESTIC CORRESPONDENCE.
Authors: None P. B. P.
Journal: JAMA (1884)

New York, November, 1884. The first annual meeting of the New York State Medical Association was an unqualified success in every way, and the inauguration of the noble project under such propitious circumstances certainly argues well for the future usefulness and prosperity of the Society. It was a notable gathering of representative men from all parts of the State, and there were in actual attendance nearly 250 out of a membership of 440, while there were also present delegates from the adjoining States, as well as from Massachusetts, the District of Columbia, the Province of New Brunswick, and the medical service of the Army and Navy. The Pennsylvania State Society was particularly well represented, and in the delegation from it were included a number of the most distinguished names in the profession in the city of Philadelphia. The amount of solid work accomplished at the meeting was remarkable, and a
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
Authors: Thomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, Sandra Cauwenberghs, Peter Fraisl, Christa Maes, Bart Jonckx, Kim De Keersmaecker, Maria Kleppe, Marc Tjwa, Thomas Schenk, Stefan Vinckier, Rita Fragoso, Maria De Mol, Karolien Beel, Sérgio Dias, Catherine Verfaillie, Richard E. Clark, Tim H. Brümmendorf, Peter Vandenberghe, Shahin Rafii, Tessa Holyoake, Andreas Hochhaus, Jan Cools, Michael Karin, Geert Carmeliet, Mieke Dewerchin, Peter Carmeliet
Journal: Cancer Cell (2020)
438O Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC
Authors: K. Park, F. Barlesi, F. Ciardiello, J. von Pawel, S. Gadgeel, T. Hida, D. Kowalski, M. Cobo Dols, D. Cortinovis, J. Leach, J. Polikoff, D.R. Gandara, C. Barrios, D.S. Chen, P. He, M. Kowanetz, M. Ballinger, D. Waterkamp, A. Sandler, A. Rittmeyer
Journal: Annals of Oncology (2016)
Human renal function following methoxyflurane anesthesia
Authors: R. B. Merkle
Journal: JAMA (1971)

The surgical repair of retinal detachment was chosen as the operative procedure to use in the investigation of the effects of methoxyflurane on renal function during the first three days after surgery. This was done in order to exclude any additive effect of hypotension, blood loss, or traumatic surgery on the kidney. In this controlled, prospective study, 25 patients received methoxyflurane and 25 received halothane. There was significant rise in the mean serum creatinine level and fall in the mean urine osmolality among patients who received methoxyflurane. No such changes were seen in those given halothane. These data suggest an effect of methoxyflurane on renal function, even when the severe symptomatic syndrome previously described does not occur.